H-CYTE (OTCMKTS:HCYTD) Stock Falls 49.5% – What’s Next?

H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report)’s share price fell 49.5% during mid-day trading on Thursday. The company traded as low as $2.02 and last traded at $2.02. Approximately 400 shares traded hands during mid-day trading, an increase of 288% from the average session volume of 103 shares. The stock had previously closed at $4.00.

H-CYTE Price Performance

The stock’s 50-day simple moving average is $2.02 and its 200 day simple moving average is $2.02.

About H-CYTE

(Get Free Report)

H-CYTE, Inc is a medical technology company focused on developing and commercializing noninvasive therapeutic products based on photobiomodulation, a treatment approach that uses specific wavelengths of light to stimulate biological responses in the body.

The company’s principal product is the H-Cyte System, a light-based therapy platform designed for use by healthcare providers. The system has been promoted for applications involving chronic health conditions, including respiratory and pain-related disorders.

See Also

• Five stocks we like better than H-CYTE
• Everyone in AI Is Quietly Copying Palantir’s Playbook
• Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
• JPMorgan Bets on Genius Sports as the Market Loses Patience
• Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question